7-OH vs CBD: A Complete Side-by-Side Comparison Guide

7-Hydroxymitragynine (7-OH) and Cannabidiol (CBD) are two of the most discussed plant-derived compounds in the U.S. retail market today. They show up on the same shelves, in the same online stores, and often in the same conversations. But despite the surface-level similarities, they come from completely different plants, belong to different chemical families, and are governed by different regulatory frameworks.

This guide compares 7-OH and CBD across the things that actually distinguish them: source, chemistry, manufacturing, product formats, legal status, and lab testing. It is written for adult consumers and retail buyers who want a clear factual picture without the marketing noise.

The Short Comparison

7-OH and CBD are different compounds from different plants with different production methods, different product categories, and different legal frameworks. 7-OH is an alkaloid derived from the kratom tree (Mitragyna speciosa). CBD is a cannabinoid extracted from the hemp plant (Cannabis sativa). They are not chemically related, not produced the same way, and not regulated the same way.

The full breakdown follows.

Quick Reference Table

Where Does Each Compound Come From?

The single biggest distinction between 7-OH and CBD is the plant of origin. They are not related botanically, chemically, or culturally.

CBD Comes From Hemp (Cannabis sativa)

Cannabidiol (CBD) is one of more than 100 cannabinoids found in the Cannabis sativa plant. Hemp is the legal classification for cannabis plants containing very low levels of delta-9 THC (under the 2018 Farm Bill, this threshold was 0.3% by dry weight).

CBD is most concentrated in the flowers and leaves of the hemp plant. Industrial hemp farming in the U.S. expanded rapidly after the 2018 Farm Bill, and CBD became one of the most widely available plant-derived compounds in the country.

7-OH Comes From Kratom (Mitragyna speciosa)

7-Hydroxymitragynine (7-OH) is one of more than 40 alkaloids found in the leaves of Mitragyna speciosa, a tropical evergreen tree in the coffee family. The tree is native to Southeast Asia, particularly Thailand, Indonesia, Malaysia, and Papua New Guinea, where its leaves have been used in traditional contexts for centuries.

In raw kratom leaf, 7-OH is a minor alkaloid, typically present at less than 2% of the total alkaloid content (and often under 0.02% by dry leaf weight). The dominant alkaloid in kratom is mitragynine, not 7-OH.

The Chemistry: Cannabinoid vs. Alkaloid

CBD and 7-OH belong to entirely different classes of organic compounds.

CBD Is a Cannabinoid

Cannabinoids are a class of chemical compounds found primarily in the cannabis plant (though some are also produced naturally in the human body, called endocannabinoids). CBD has the molecular formula C₂₁H₃₀O₂ and is structurally classified as a phytocannabinoid.

Other well-known cannabinoids in the same family include THC (delta-9 tetrahydrocannabinol), CBG (cannabigerol), CBN (cannabinol), and CBC (cannabichromene). All cannabinoids share a basic structural backbone but differ in their specific arrangement of atoms.

7-OH Is an Alkaloid

Alkaloids are a broad class of naturally occurring organic compounds that contain at least one nitrogen atom. The alkaloid family is enormous and includes compounds as varied as caffeine, theobromine, and quinine.

7-OH is specifically an indole alkaloid, with the molecular formula C₂₃H₃₀N₂O₅. It shares a structural backbone with mitragynine, the dominant kratom alkaloid, and the two compounds differ by a single hydroxyl group (the "7-hydroxy" in the name).

The bottom line: CBD and 7-OH are not in the same chemical family. They have different molecular structures, different elemental compositions, and different relationships to the plants they come from.

How Each Compound Is Manufactured?

The production processes for CBD and 7-OH are also distinct.

CBD Production: Extraction From Hemp

Most commercial CBD is produced through one of three extraction methods:

1. CO₂ extraction. Pressurized carbon dioxide pulls cannabinoids and terpenes from hemp biomass. Considered a high-quality method because it avoids residual solvents.
2. Ethanol extraction. Food-grade ethanol acts as a solvent to dissolve cannabinoids from plant material. The ethanol is then evaporated off.
3. Hydrocarbon extraction. Solvents like butane or propane extract cannabinoids efficiently but require careful purging.

After extraction, the resulting concentrate can be further refined into:

• Full-spectrum CBD: Contains CBD plus the full range of other cannabinoids (including up to 0.3% THC) and terpenes from the hemp plant.

• Broad-spectrum CBD: Contains CBD and other cannabinoids except THC, which is removed.

• CBD isolate: Pure crystalline CBD, typically 99%+ purity, with all other plant compounds removed.

Product Formats: How Consumers Encounter Each One

Both compounds appear in a wide range of formats, but the distribution and presentation differ.

Common CBD Product Formats

CBD has been on the U.S. market since 2018 and is available in nearly every consumable and topical form imaginable:

• Oils and tinctures. The original CBD format, typically held under the tongue.

• Gummies and edibles. Pre-dosed, flavored, widely available.

• Capsules and softgels. Pre-measured doses in a familiar pill format.

• Topicals. Creams, balms, salves, and roll-ons applied to the skin.

• Vape products. CBD-infused vape oils and disposable devices.

• Beverages. Sparkling waters, teas, coffees, and other infused drinks.

• Pet products. CBD oils, treats, and chews formulated for animals.

• Bath and body. Bath bombs, lotions, lip balms, and soaps.

Common 7-OH Product Formats

7-OH product formats are narrower and tend to focus on rapid, precise delivery:

• Tablets. Compressed pills, often sublingual or swallowed.

• Dissolvable strips. Thin films that dissolve in the mouth.

• Shots and liquids. Small ready-to-use liquid formats.

• Gummies. Pre-dosed chewable formats.

• Powders. Concentrated 7-OH measured by the user.

7-OH is rarely sold as a topical, pet product, or beverage. The product line is significantly more focused than the CBD market.

Industry Standards and Lab Testing

Both compounds are typically sold with third-party lab testing, though the standards and certifications differ.

CBD Lab Testing Standards

Reputable CBD products are accompanied by a Certificate of Analysis (COA) from an ISO 17025-accredited third-party laboratory. A CBD COA generally tests for:

• Cannabinoid potency (CBD, THC, and minor cannabinoids)

• Terpene profile (in full-spectrum products)

• Heavy metals (lead, mercury, cadmium, arsenic)

• Pesticides

• Residual solvents

• Microbial contamination

• Mycotoxins

Many CBD brands publish QR codes on packaging that link directly to the COA for that specific batch.

7-OH Lab Testing Standards

7-OH lab testing is less formalized as an industry standard, but reputable brands also provide third-party COAs. A 7-OH COA generally tests for:

• 7-OH and mitragynine alkaloid concentration

• Other kratom alkaloid presence

• Heavy metals

• Microbial contamination

• Residual solvents from extraction

Because the 7-OH industry is younger than the CBD industry, testing protocols are still evolving. Buyers should look for batch-specific COAs from accredited labs, just as with CBD.

Legal and Regulatory Framework

The legal frameworks around CBD and 7-OH are very different, and both are evolving as of 2026.

CBD Legal Framework

Hemp-derived CBD became federally legal in the United States with the passage of the 2018 Farm Bill, which removed hemp (defined as Cannabis sativa containing less than 0.3% delta-9 THC by dry weight) from the Controlled Substances Act. CBD products derived from compliant hemp have been broadly available in mainstream retail since.

Recent developments include:

• Section 781 of the November 2025 Continuing Resolution redefines hemp using total THC content, with enforcement beginning November 12, 2026.

• The new definition imposes a 0.4 mg total THC per container limit on finished hemp-derived products.

• The change primarily affects intoxicating hemp products (delta-8, THCA, etc.) rather than non-intoxicating CBD.

• Multiple bills are currently active in Congress to delay, modify, or repeal these provisions.

• States such as California, Texas, Colorado, and Ohio have introduced their own additional CBD-related legislation.

CBD itself, particularly in non-intoxicating forms, retains broad federal legality as of April 2026.

7-OH Legal Framework

7-OH has a more complicated and more recent regulatory history.

• 7-OH is federally unscheduled in the United States as of April 2026.

• The FDA has stated that 7-OH does not meet the standard for a lawful dietary supplement or food ingredient.

• The FDA recommended Schedule I classification for concentrated 7-OH products to the DEA in July 2025, with rulemaking still in progress.

• Some states have introduced or passed targeted 7-OH restrictions while leaving natural kratom leaf exempt.

• Kratom Consumer Protection Acts (KCPAs) in several states establish labeling, age (21+), and purity standards.

The regulatory environment for 7-OH is changing more quickly than for CBD. Retailers and consumers should verify the current legal status in their state before purchasing.

Market Position and Industry Context

The two compounds occupy different positions in the U.S. market.

CBD Market Snapshot

The U.S. CBD market is mature and broadly distributed. As of 2026:

• Hemp-derived products represent a multi-billion dollar industry.

• CBD products are sold through mainstream retail, including pharmacies, grocery stores, and convenience chains, in addition to specialty shops and online.

• The market has consolidated since the early post-2018 boom, with established brands holding significant share.

• The non-intoxicating CBD segment is generally distinct from the intoxicating hemp-derived THC segment in regulatory discussions.

7-OH Market Snapshot

The 7-OH market is younger and more concentrated:

• 7-OH products entered the broader U.S. market primarily after 2020.

• Distribution is heavier in smoke shops, specialty retailers, and direct-to-consumer online stores.

• Mainstream retail presence is limited compared to CBD.

• The product category is closely watched by federal regulators, which has shaped industry self-regulation efforts.

• Industry groups have pushed for clearer labeling, age verification, and purity standards.

Storage and Shelf Life Differences

Both compounds are organic molecules that degrade over time, but they degrade at different rates and have different optimal storage conditions.

CBD Storage

CBD is sensitive to:

• Light (especially UV)

• Heat (above room temperature)

• Air (oxidation, especially in oils)

Most CBD oils have a shelf life of 12 to 24 months when stored in a cool, dark place. Topicals typically last 12 to 18 months. Edibles vary by formulation but often follow standard food shelf-life rules.

7-OH Storage

7-OH is similarly sensitive to light, heat, and moisture. Tablets and dissolvable strips are particularly vulnerable to humidity. Most 7-OH products have a manufacturer-stated shelf life of 12 to 24 months when stored properly.

For both categories, the key storage rules are similar: cool, dark, dry, and tightly sealed.

Also Read: How to Store 7-OH Tablets for Maximum Potency

Frequently Asked Questions

Are 7-OH and CBD the same thing?

No. 7-OH is an alkaloid from the kratom tree (Mitragyna speciosa), while CBD is a cannabinoid from the hemp plant (Cannabis sativa). They come from different plants, belong to different chemical classes, and are produced through different processes.

Can 7-OH and CBD products be sold at the same store?

In many states, yes. Smoke shops, specialty retailers, and online stores often carry both. However, the legal frameworks governing each are different, and some states have specific restrictions on one or both. Retailers should verify state and local rules before stocking either product.

Is CBD or 7-OH more widely available?

CBD is significantly more widely distributed in the U.S. as of 2026, with mainstream retail presence in pharmacies, grocery stores, and convenience chains. 7-OH is more commonly found in specialty shops and online, with limited mainstream retail distribution.

How are 7-OH and CBD products tested?

Both categories are typically sold with Certificates of Analysis (COAs) from third-party labs, which test for compound concentration, heavy metals, microbial contamination, and residual solvents. CBD testing standards are more established due to the longer market history.

Do 7-OH products contain CBD, or vice versa?

No. 7-OH and CBD come from different plants and are not produced together. A 7-OH product will not contain CBD, and a CBD product will not contain 7-OH. Some retailers carry both compounds in separate product lines, but they are not blended in standard formulations.

Is 7-OH legal everywhere CBD is legal?

No. CBD is federally legal under the 2018 Farm Bill (with evolving restrictions), while 7-OH operates under a different and less settled regulatory framework. Several states permit CBD but restrict 7-OH or kratom products. Always check current state and local laws.

Which one has been on the U.S. market longer?

CBD has had broad federal legal status since the 2018 Farm Bill, giving it a substantial head start in mainstream distribution. 7-OH as a distinct product category is more recent, gaining significant market presence after 2020.

Also Read: 7OH vs MIT

Summary

7-OH and CBD are two distinct plant-derived compounds that often appear in similar retail environments but have very little else in common. CBD is a cannabinoid extracted from hemp, with an established legal framework dating to 2018 and broad mainstream distribution. 7-OH is a semi-synthetic alkaloid derived from the kratom plant, with a more recent market history and an evolving regulatory environment.

Understanding the differences in source plant, chemistry, manufacturing, product formats, and legal status helps both consumers and retailers make informed decisions about each category on its own terms.

---

Disclaimer: This article is provided for informational and educational purposes only. It is not medical, legal, or professional advice. Statements about the products discussed have not been evaluated by the U.S. Food and Drug Administration. Intended for adult readers aged 21 or older. Laws regarding 7-hydroxymitragynine and cannabidiol vary by jurisdiction and are subject to change. Readers are responsible for understanding and complying with the laws in their area.